The Metrix blog

Metrix's top picks

The reimbursement landscape just changed. Does your FRM team know what to tell their accounts?

Access is a critical driver of both launch success and long-term growth. When reimbursement rules shift, the impact is felt immediately at the account level, where providers are making real decisions about patient access, financial risk, and operational feasibility. Recent Medicare updates are the latest reminder of how frequently those rules evolve. Changes tied to…

Building field access capability from the ground up: Lessons from a launch-ready team

Field access has quietly become one of the most important…

What keeps NSM strategy alive once the field is back to work?

The ballroom is full. The strategy is clear. The energy…

Why AI makes us more human in training

In life sciences, the most impactful learning experiences don’t just…

Stay ahead of the game with regular updates

All results

The pharma post-launch training gap
Learning, Product launch

The pharma post-launch training gap: Why field performance drops after the honeymoon phase

The national launch meeting is over. The field team has completed their training. They know the product,…

Market Access

The reimbursement landscape just changed. Does your FRM team know what to tell their accounts?

Access is a critical driver of both launch success and long-term growth. When reimbursement rules shift, the…

Learning, Market Access, Product launch

Building field access capability from the ground up: Lessons from a launch-ready team

Field access has quietly become one of the most important levers in a successful launch. Yet in…

Learning, NSMs and POAs

What keeps NSM strategy alive once the field is back to work?

The ballroom is full. The strategy is clear. The energy is high. National Sales Meetings do exactly…

AI, Behavioral Science, Learning

Why AI makes us more human in training

In life sciences, the most impactful learning experiences don’t just transfer knowledge; they create confidence, empathy, and…

Learning

Agility in action: How pharma teams can thrive through disruption

Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges are steeper. Market disruptions, mergers and acquisitions,…

Why rare disease training needs a new playbook
Learning, Rare Diseases

Why pharma training needs a new playbook for rare disease

The rare disease sector is no longer a niche. Nearly half of all new drug approvals in the U.S….

Learning

The experiential edge: Why learning by doing drives behavior change

If you’ve ever tried to learn to swim from a manual, you know it doesn’t work. You…

Using patient narratives to transform pharma training
Behavioral Science, Learning, Storytelling

Storytelling with purpose: Using patient narratives to transform pharma training

In pharma, facts and data are everywhere. Clinical results, safety data, prescribing guidelines, these are essential, but…

Why intelligent personalization is the future of pharma L and D
AI, Learning, Personalization

Why intelligent personalization is the future of pharma L&D

In pharma, training has never been “one-size-fits-all.” Your sales rep in oncology needs a very different learning…

Behavioral Science, Learning

From learning to business impact: Closing the measurement gap in pharma training

Pharma leaders know training is a critical investment. Whether it’s onboarding new hires, preparing a field team for launch,…

BehaviorBridge, Learning

From passive to performance: Our 4-step method to drive lasting behavior change

In pharma, knowing isn’t enough. Performance happens when knowledge turns into action and that’s where most training…

Scroll to Top